Impact of host genetic polymorphisms on vaccine induced antibody response

References

• Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008; 86:140-6; PMID:18297169; http://dx.doi.org/10.2471/BLT.07.040089
   PubMed Web of Science ®Google Scholar
• Kaslow DC, Biernaux S. RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap. Vaccine 2015; 33(52):7425-32
   PubMed Web of Science ®Google Scholar
• Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58:470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790
   PubMed Web of Science ®Google Scholar
• Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9:185-94; PMID:19240757; http://dx.doi.org/10.1038/nri2508
   PubMed Web of Science ®Google Scholar
• Faucette AN, Unger BL, Gonik B, Chen K. Maternal vaccination: moving the science forward. Hum Reprod Update 2015; 21:119-35; PMID:25015234; http://dx.doi.org/10.1093/humupd/dmu041
   PubMed Web of Science ®Google Scholar
• Smith SA, Poland GA, American Diabetes A. Influenza and pneumococcal immunization in diabetes. Diabetes Care 2004; 27 Suppl 1:S111-113; PMID:14693944
   PubMedGoogle Scholar
• Gelinck LB, Teng YK, Rimmelzwaan GF, van den Bemt BJ, Kroon FP, van Laar JM. Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 2007; 66:1402-3; PMID:17881666; http://dx.doi.org/10.1136/ard.2007.071878
   PubMed Web of Science ®Google Scholar
• van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 2010; 62:75-81; PMID:20039396; http://dx.doi.org/10.1002/art.25033
   PubMed Web of Science ®Google Scholar
• Manuel O, Pascual M, Hoschler K, Giulieri S, Alves D, Ellefsen K, Bart PA, Venetz JP, Calandra T, Cavassini M. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011; 52:248-56; PMID:21288852; http://dx.doi.org/10.1093/cid/ciq104
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9:493-504; PMID:19628174; http://dx.doi.org/10.1016/S1473-3099(09)70175-6
   PubMed Web of Science ®Google Scholar
• Ljungman P. Vaccination of immunocompromised patients. Clin Microbiol Infect 2012; 18 Suppl 5:93-9; PMID:23051059; http://dx.doi.org/10.1111/j.1469-0691.2012.03971.x
   PubMed Web of Science ®Google Scholar
• Hagan T, Nakaya HI, Subramaniam S, Pulendran B. Systems vaccinology: Enabling rational vaccine design with systems biological approaches. Vaccine 2015; 33(40):5294-301; PMID:25858860
   PubMed Web of Science ®Google Scholar
• Germain RN. Vaccines and the future of human immunology. Immunity 2010; 33:441-50; PMID:21029956; http://dx.doi.org/10.1016/j.immuni.2010.09.014
   PubMed Web of Science ®Google Scholar
• Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8:737-44; PMID:18728636; http://dx.doi.org/10.1038/nri2394
   PubMed Web of Science ®Google Scholar
• O'Shea D, Widmer LA, Stelling J, Egli A. Changing face of vaccination in immunocompromised hosts. Curr Infect Dis Rep 2014; 16:420; PMID:24992978; http://dx.doi.org/10.1007/s11908-014-0420-2
   PubMed Web of Science ®Google Scholar
• Egli A, Santer D, Barakat K, Zand M, Levin A, Vollmer M, Weisser M, Khanna N, Kumar D, Tyrrell L, et al. Vaccine adjuvants–understanding molecular mechanisms to improve vaccines. Swiss Med Wkly 2014; 144:w13940; PMID:24844935
   PubMed Web of Science ®Google Scholar
• Franco LM, Bucasas KL, Wells JM, Nino D, Wang X, Zapata GE, Arden N, Renwick A, Yu P, Quarles JM, et al. Integrative genomic analysis of the human immune response to influenza vaccination. Elife 2013; 2:e00299; PMID:23878721; http://dx.doi.org/10.7554/eLife.00299
   PubMed Web of Science ®Google Scholar
• Tan PL, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz VS. Twin studies of immunogenicity–determining the genetic contribution to vaccine failure. Vaccine 2001; 19:2434-9; PMID:11257374; http://dx.doi.org/10.1016/S0264-410X(00)00468-0
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered 2011; 72:206-23; PMID:22086389; http://dx.doi.org/10.1159/000331585
   PubMed Web of Science ®Google Scholar
• Ferreira PG, Dermitzakis ET. Immune response is a personal matter. Elife 2013; 2:e00899; PMID:23878727; http://dx.doi.org/10.7554/eLife.00899
   PubMedGoogle Scholar
• Pulendran B. Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A 2014; 111:12300-6; PMID:25136102; http://dx.doi.org/10.1073/pnas.1400476111
   PubMed Web of Science ®Google Scholar
• Nauta JJ, Beyer WE, Osterhaus AD. On the relationship between mean antibody level, seroprotection and clinical protection from influenza. Biologicals 2009; 37:216-21; PMID:19268607; http://dx.doi.org/10.1016/j.biologicals.2009.02.002
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84; PMID:20404851; http://dx.doi.org/10.1038/ni.1863
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6:644-58; PMID:16932750; http://dx.doi.org/10.1038/nri1900
   PubMed Web of Science ®Google Scholar
• Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013; 13:227-42; PMID:23470321; http://dx.doi.org/10.1038/nri3405
   PubMed Web of Science ®Google Scholar
• Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996; 4:313-9; PMID:8624821; http://dx.doi.org/10.1016/S1074-7613(00)80439-2
   PubMed Web of Science ®Google Scholar
• Mari N, Hercor M, Denanglaire S, Leo O, Andris F. The capacity of Th2 lymphocytes to deliver B-cell help requires expression of the transcription factor STAT3. Eur J Immunol 2013; 43(6):1489-98; PMID:23504518
   PubMed Web of Science ®Google Scholar
• Randolph DA, Huang G, Carruthers CJ, Bromley LE, Chaplin DD. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science 1999; 286:2159-62; PMID:10591648; http://dx.doi.org/10.1126/science.286.5447.2159
   PubMed Web of Science ®Google Scholar
• MacLeod H, Wetzler LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE 2007; 2007:pe48; PMID:17785715; http://dx.doi.org/10.1126/stke.4022007pe48
   PubMedGoogle Scholar
• Tartey S, Matsushita K, Imamura T, Wakabayashi A, Ori D, Mino T, Takeuchi O. Essential Function for the Nuclear Protein Akirin2 in B Cell Activation and Humoral Immune Responses. J Immunol 2015; 195:519-27; PMID:26041538; http://dx.doi.org/10.4049/jimmunol.1500373
   PubMed Web of Science ®Google Scholar
• Albert R. Scale-free networks in cell biology. J Cell Sci 2005; 118:4947-57; PMID:16254242; http://dx.doi.org/10.1242/jcs.02714
   PubMed Web of Science ®Google Scholar
• Han HW, Ohn JH, Moon J, Kim JH. Yin and Yang of disease genes and death genes between reciprocally scale-free biological networks. Nucleic Acids Res 2013; 41:9209-17; PMID:23935122; http://dx.doi.org/10.1093/nar/gkt683
   PubMed Web of Science ®Google Scholar
• Wagner A. Robustness against mutations in genetic networks of yeast. Nat Genet 2000; 24:355-61; PMID:10742097; http://dx.doi.org/10.1038/74174
   PubMed Web of Science ®Google Scholar
• Albert R, Jeong H, Barabasi AL. Error and attack tolerance of complex networks. Nature 2000; 406:378-82; PMID:10935628; http://dx.doi.org/10.1038/35019019
   PubMed Web of Science ®Google Scholar
• Stelling J, Sauer U, Szallasi Z, Doyle FJ, 3rd, Doyle J. Robustness of cellular functions. Cell 2004; 118:675-85; PMID:15369668; http://dx.doi.org/10.1016/j.cell.2004.09.008
   PubMed Web of Science ®Google Scholar
• Kitano H. Biological robustness. Nat Rev Genet 2004; 5:826-37; PMID:15520792; http://dx.doi.org/10.1038/nrg1471
   PubMed Web of Science ®Google Scholar
• Lavoie TB, Kalie E, Crisafulli-Cabatu S, Abramovich R, DiGioia G, Moolchan K, Pestka S, Schreiber G. Binding and activity of all human α interferon subtypes. Cytokine 2011; 56:282-9; PMID:21856167; http://dx.doi.org/10.1016/j.cyto.2011.07.019
   PubMed Web of Science ®Google Scholar
• Abdul-Sater AA, Majoros A, Plumlee CR, Perry S, Gu AD, Lee C, Shresta S, Decker T, Schindler C. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs. J Immunol 2015; 195:210-6; PMID:26019270; http://dx.doi.org/10.4049/jimmunol.1401139
   PubMed Web of Science ®Google Scholar
• Kohler UA, Bohm F, Rolfs F, Egger M, Hornemann T, Pasparakis M, Weber A, Werner S. NF-kappaB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. J Hepatol 2016; 64(1):94-102; PMID:26348541.
   PubMed Web of Science ®Google Scholar
• Bank S, Skytt Andersen P, Burisch J, Pedersen N, Roug S, Galsgaard J, Ydegaard Turino S, Broder Brodersen J, Rashid S, Kaiser Rasmussen B, et al. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PLoS One 2014; 9:e98815; PMID:24971461; http://dx.doi.org/10.1371/journal.pone.0098815
   PubMedGoogle Scholar
• Gough SC, Simmonds MJ. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics 2007; 8:453-65; PMID:19412418; http://dx.doi.org/10.2174/138920207783591690
   PubMed Web of Science ®Google Scholar
• Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, Casanova JL, Israël A. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 2002; 11:2371-5; PMID:12351572; http://dx.doi.org/10.1093/hmg/11.20.2371
   PubMed Web of Science ®Google Scholar
• Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351:2715-29; PMID:15616206; http://dx.doi.org/10.1056/NEJMra033540
   PubMed Web of Science ®Google Scholar
• Scheinfeld N. A comprehensive review and evaluation of the side effects of the tumor necrosis factor α blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 2004; 15:280-94; PMID:15370396; http://dx.doi.org/10.1080/09546630410017275
   PubMedGoogle Scholar
• Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 2011; 473:463-9; PMID:21614073; http://dx.doi.org/10.1038/nature10124
   PubMed Web of Science ®Google Scholar
• Prachi P, Donati C, Masciopinto F, Rappuoli R, Bagnoli F. Deep sequencing in pre- and clinical vaccine research. Public Health Genomics 2013; 16:62-8; PMID:23548719; http://dx.doi.org/10.1159/000345611
   PubMed Web of Science ®Google Scholar
• Buhler S, Sanchez-Mazas A. HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events. PLoS One 2011; 6:e14643; PMID:21408106; http://dx.doi.org/10.1371/journal.pone.0014643
   PubMedGoogle Scholar
• Brookes AJ. The essence of SNPs. Gene 1999; 234:177-86; PMID:10395891; http://dx.doi.org/10.1016/S0378-1119(99)00219-X
   PubMed Web of Science ®Google Scholar
• Snyder MW, Adey A, Kitzman JO, Shendure J. Haplotype-resolved genome sequencing: experimental methods and applications. Nat Rev Genet 2015; 16:344-58; PMID:25948246; http://dx.doi.org/10.1038/nrg3903
   PubMed Web of Science ®Google Scholar
• Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29:229-32; PMID:11586305; http://dx.doi.org/10.1038/ng1001-229
   PubMed Web of Science ®Google Scholar
• Kim S, Misra A. SNP genotyping: technologies and biomedical applications. Annu Rev Biomed Eng 2007; 9:289-320; PMID:17391067; http://dx.doi.org/10.1146/annurev.bioeng.9.060906.152037
   PubMed Web of Science ®Google Scholar
• Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921; PMID:11237011; http://dx.doi.org/10.1038/35057062
   PubMed Web of Science ®Google Scholar
• Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928-33; PMID:11237013; http://dx.doi.org/10.1038/35057149
   PubMed Web of Science ®Google Scholar
• Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280:1077-82; PMID:9582121; http://dx.doi.org/10.1126/science.280.5366.1077
   PubMed Web of Science ®Google Scholar
• Musumeci L, Arthur JW, Cheung FS, Hoque A, Lippman S, Reichardt JK. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Hum Mutat 2010; 31:67-73; PMID:19877174; http://dx.doi.org/10.1002/humu.21137
   PubMed Web of Science ®Google Scholar
• Mitchell AA, Zwick ME, Chakravarti A, Cutler DJ Discrepancies in dbSNP confirmation rates and allele frequency distributions from varying genotyping error rates and patterns. Bioinformatics 2004; 20:1022-32; PMID:14764571; http://dx.doi.org/10.1093/bioinformatics/bth034
   PubMed Web of Science ®Google Scholar
• International HapMap C, Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467:52-8; PMID:20811451; http://dx.doi.org/10.1038/nature09298
   PubMed Web of Science ®Google Scholar
• Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol 2009; 578:3-22; PMID:19768584; http://dx.doi.org/10.1007/978-1-60327-411-1_1
   PubMedGoogle Scholar
• Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 2013; 4:1418; PMID:23361009; http://dx.doi.org/10.1038/ncomms2433
   PubMed Web of Science ®Google Scholar
• Dong ZX, Zhou HJ, Xiang XG, Guo SM, Zhuang Y, Zhao GD, Xie Q. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population. J Dig Dis 2015; 16:90-7; PMID:25312023; http://dx.doi.org/10.1111/1751-2980.12202
   PubMed Web of Science ®Google Scholar
• Fernandez-Carrillo C, Coto-Llerena M, Gonzalez P, Crespo G, Mensa L, Caro-Pérez N, Gambato M, Navasa M, Forns X, Pérez-del-Pulgar S. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation. J Clin Virol 2014; 61:282-5; PMID:25130512; http://dx.doi.org/10.1016/j.jcv.2014.07.015
   PubMed Web of Science ®Google Scholar
• Egli A, Santer DM, O'Shea D, Barakat K, Syedbasha M, Vollmer M, Baluch A, Bhat R, Groenendyk J, Joyce MA, et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog 2014; 10:e1004556; PMID:25503988; http://dx.doi.org/10.1371/journal.ppat.1004556
   PubMed Web of Science ®Google Scholar
• Lazear HM, Nice TJ, Diamond MS. Interferon-lambda: Immune Functions at Barrier Surfaces and Beyond. Immunity 2015; 43:15-28; PMID:26200010; http://dx.doi.org/10.1016/j.immuni.2015.07.001
   PubMed Web of Science ®Google Scholar
• Egli A, Santer MD, O'Shea D, Tyrrell DL, Houghton M. The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Infect Dis 2014;3(7):e51. http://dx.doi.org/10.1038/emi.2014.51
   Web of Science ®Google Scholar
• Chinnaswamy S, Chatterjee S, Boopathi R, Mukherjee S, Bhattacharjee S, Kundu TK. A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-kappaB-mediated gene transcription. PLoS One 2013; 8:e75495; PMID:24116050; http://dx.doi.org/10.1371/journal.pone.0075495
   PubMedGoogle Scholar
• Fischer J, Bohm S, Scholz M, Muller T, Witt H, George J, Sarrazin C, Susser S, Schott E, Suppiah V, et al. Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology 2012; 55:1700-10; PMID:22234924; http://dx.doi.org/10.1002/hep.25582
   PubMed Web of Science ®Google Scholar
• Aparicio E, Parera M, Franco S, Perez-Alvarez N, Tural C, Clotet B, Martínez MA. IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients. PLoS One 2010; 5:e13771; PMID:21048934; http://dx.doi.org/10.1371/journal.pone.0013771
   PubMed Web of Science ®Google Scholar
• Resham S, Manzoor S, Imran M, Saalim M, Naseem S, Azam S. Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response. APMIS 2015; 123(9):765-71
   PubMed Web of Science ®Google Scholar
• Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nat Genet 2009; 41:1100-4; PMID:19749758; http://dx.doi.org/10.1038/ng.447
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41:1105-9; PMID:19749757; http://dx.doi.org/10.1038/ng.449
   PubMed Web of Science ®Google Scholar
• Bibert S, Wojtowicz A, Taffe P, Manuel O, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M, et al. The IFNL3/4 DeltaG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. AIDS 2014; 28:1885-9; PMID:25259701; http://dx.doi.org/10.1097/QAD.0000000000000379
   PubMed Web of Science ®Google Scholar
• Manuel O, Wojtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C, et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 2015; 211:906-14; PMID:25301956; http://dx.doi.org/10.1093/infdis/jiu557
   PubMed Web of Science ®Google Scholar
• Haralambieva IH, Ovsyannikova IG, Umlauf BJ, Vierkant RA, Shane Pankratz V, Jacobson RM, Poland GA. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine 2011; 29:8988-97; PMID:21939710; http://dx.doi.org/10.1016/j.vaccine.2011.09.043
   PubMed Web of Science ®Google Scholar
• Srinivas S, Dai J, Eskdale J, Gallagher GE, Megjugorac NJ, Gallagher G. Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 2008; 125:492-502; PMID:18547367; http://dx.doi.org/10.1111/j.1365-2567.2008.02862.x
   PubMed Web of Science ®Google Scholar
• Jordan WJ, Eskdale J, Srinivas S, Pekarek V, Kelner D, Rodia M, Gallagher G. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007; 8:254-61; PMID:17361203; http://dx.doi.org/10.1038/sj.gene.6364382
   PubMed Web of Science ®Google Scholar
• Dai J, Megjugorac NJ, Gallagher GE, Yu RY, Gallagher G. IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood 2009; 113:5829-38; PMID:19346497; http://dx.doi.org/10.1182/blood-2008-09-179507
   PubMed Web of Science ®Google Scholar
• Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, Ubel C, Kotenko SV, Sideras P, Lehr HA, Tepe M, et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 2011; 3:348-61; PMID:21538995; http://dx.doi.org/10.1002/emmm.201100142
   PubMed Web of Science ®Google Scholar
• Steck T, Albert P, Weppler M, Becker W, Spingler H, Würfel W, von Hertwig I. [The effect of an intrauterine device on passive sperm transport in the uterus and fallopian tube at the time of ovulation]. Gynakol Rundsch 1989; 29 Suppl 2:430-2; PMID:2613070; http://dx.doi.org/10.1159/000271144
   PubMedGoogle Scholar
• Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, Bunce M, Welsh KI, Marshall SE, Oxford J. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 2002; 185:114-7; PMID:11756990; http://dx.doi.org/10.1086/338014
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008; 26 Suppl 4:D35-40; PMID:19230157; http://dx.doi.org/10.1016/j.vaccine.2008.07.065
   PubMed Web of Science ®Google Scholar
• Hennig BJ, Fielding K, Broxholme J, Diatta M, Mendy M, Moore C, Pollard AJ, Rayco-Solon P, Sirugo G, van der Sande MA, et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One 2008; 3:e1898; PMID:18365030; http://dx.doi.org/10.1371/journal.pone.0001898
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine 2012; 30:4182-9; PMID:22542470; http://dx.doi.org/10.1016/j.vaccine.2012.04.055
   PubMed Web of Science ®Google Scholar
• Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine 2011; 29:7883-95; PMID:21875636; http://dx.doi.org/10.1016/j.vaccine.2011.08.083
   PubMed Web of Science ®Google Scholar
• Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients. Immunogenetics 2014; 66:493-9; PMID:24811271; http://dx.doi.org/10.1007/s00251-014-0776-3
   PubMed Web of Science ®Google Scholar
• Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, Poland GA. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. PLoS One 2014; 9:e99997; PMID:24945853; http://dx.doi.org/10.1371/journal.pone.0099997
   PubMedGoogle Scholar
• Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005; 366:1315-23; PMID:16214603; http://dx.doi.org/10.1016/S0140-6736(05)67531-9
   PubMed Web of Science ®Google Scholar
• Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet 2011; 20:3893-8; PMID:21764829; http://dx.doi.org/10.1093/hmg/ddr302
   PubMed Web of Science ®Google Scholar
• de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005; 37:1217-23; PMID:16244653; http://dx.doi.org/10.1038/ng1669
   PubMed Web of Science ®Google Scholar
• Hong EP, Park JW. Sample size and statistical power calculation in genetic association studies. Genomics Inform 2012; 10:117-22; PMID:23105939; http://dx.doi.org/10.5808/GI.2012.10.2.117
   PubMedGoogle Scholar
• Spencer CC, Su Z, Donnelly P, Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009; 5:e1000477; PMID:19492015; http://dx.doi.org/10.1371/journal.pgen.1000477
   PubMed Web of Science ®Google Scholar
• Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus AD Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 2004; 103:125-32; PMID:15163500
   PubMed Web of Science ®Google Scholar
• King MC, Marks JH, Mandell JB, New York Breast Cancer Study G Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302:643-6; PMID:14576434; http://dx.doi.org/10.1126/science.1088759
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5:591-602; PMID:16056258; http://dx.doi.org/10.1038/nrc1670
   PubMed Web of Science ®Google Scholar
• Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010; 84:523-38; PMID:20585380; http://dx.doi.org/10.1007/s11192-009-0146-3
   PubMed Web of Science ®Google Scholar
• Becker V, Schilling M, Bachmann J, Baumann U, Raue A, Maiwald T, Timmer J, Klingmüller U. Covering a broad dynamic range: information processing at the erythropoietin receptor. Science 2010; 328:1404-8; PMID:20488988; http://dx.doi.org/10.1126/science.1184913
   PubMed Web of Science ®Google Scholar
• Maiwald T, Schneider A, Busch H, Sahle S, Gretz N, Weiss TS, Kummer U, Klingmüller U. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling. FEBS J 2010; 277:4741-54; PMID:20964804; http://dx.doi.org/10.1111/j.1742-4658.2010.07880.x
   PubMed Web of Science ®Google Scholar
• Kholodenko BN. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 2006; 7:165-76; PMID:16482094; http://dx.doi.org/10.1038/nrm1838
   PubMed Web of Science ®Google Scholar
• Rangamani P, Iyengar R. Modelling cellular signalling systems. Essays Biochem 2008; 45:83-94; PMID:18793125; http://dx.doi.org/10.1042/bse0450083
   PubMed Web of Science ®Google Scholar
• Kitano H. Computational systems biology. Nature 2002; 420:206-10; PMID:12432404; http://dx.doi.org/10.1038/nature01254
   PubMed Web of Science ®Google Scholar
• Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Biotechnol 2004; 22:1253-9; PMID:15470465; http://dx.doi.org/10.1038/nbt1017
   PubMed Web of Science ®Google Scholar